Pain Management Drugs Market – Global Industry Analysis and Forecast (2022-2029)


Pain Management Drugs Market was valued at US$ 38.91 Bn in 2021 and is expected to reach US$ 58.16 Bn by 2029, at a CAGR of 5.15% during a forecast period.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

Global Pain Management Drugs Market

To know about the Research Methodology:-Request Free Sample Report

Pain Management Drugs Market Dynamics:

Pain management is used for treating all types of pain containing musculoskeletal, spinal, and neuropathic pain disorders. It is used to improve the quality of life of individuals suffering from pain. Growth in the geriatric population is the major factor that drives the growth of the global pain management market due to elderly people are more likely to suffer from joint pain as well as chronic disorders such as heart disease, stroke, diabetes, and cancer.

The rise in alertness regarding the side effects of pain medication, and growing the occurrence & prevalence of chronic diseases are also boosting the growth of the market. Availability of alternative therapies and a rise in drug mistreatment are obstructing the growth of the pain management drugs market.

 Pain Management Drugs Market Segment Analysis:

Prescription of medicine is leading the market, owing to the drugs that are only available with a valid prescription from a doctor. Prescription drugs must pass through many clinical trial phases, approval by the food and drug administration (FDA), and observed for safety & side effects even after the drug is on the market. OTC drugs are available without consulting a prescriber or pharmacist, though the patient is to be aware of these drugs that still carry a risk. OTC drugs are monitored by the food and drug administration, but it is not as stringent as the process prescription drugs must go through.

Migraine is very common, and it is a type of headache-related disorder with sensitivity towards odor, light, or acoustics. Migraines can be treated with abortive and preventive medicines. Abortive medications work quickly and are especially useful for people who have nausea & vomiting related to their migraines. Abortive medications can be taken by self-injection, mouth, and skin patch. Fibromyalgia is a common type of chronic pain where the patient suffers from musculoskeletal pain along with memory, fatigue, sleep, and mood issues.

Pain Management Drugs Market Regional Insights:

Asia-Pacific is estimated to be the fastest-growing region for the pain management drugs market owing to the presence of a larger patient pool and the growth in healthcare expenditure in this region. Japan is the largest contributor and China & India are the fastest-growing countries in the Asia-Pacific region in the global pain management drugs markets.

The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

Pain Management Drugs Market, Key Highlights:

• Global Pain Management Drugs Market analysis and forecast, in terms of value.
• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Pain Management Drugs Market
• Global Pain Management Drugs Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
• Global Pain Management Drugs Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
• Global Pain Management Drugs Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Pain Management Drugs Market are also profiled.

The Scope of the Global Pain Management Drugs Market:  Inquire before buying






Global Pain Management Drugs Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 38.91 Bn.




Forecast Period 2022 to 2029 CAGR:
5.15%
Market Size in 2029:
US $ 58.16 Bn.




 Segments Covered:
by Category
• Prescription-Based Drugs
• Over-The-Counter (OTC) Drugs




by Therapeutic Indication
• Post-Operative Pain
• Low-Back Pain
• Rheumatoid Arthritis Pain
• Osteoarthritis Pain
• Cancer Pain
• Migraine
• Neuropathic Pain
• Fibromyalgia
• Others




by Brands
• Maxalt
• Zomig
• Qutenza
• Lidoderm
• Savella
• Imitrex
• Voltaren Gel
• Celebrex
• Cymbalta
• Others






Global Pain Management Drugs Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Global Pain Management Drugs Market Key Players:

• Pfizer, Inc.
• Purdue Pharma L.P.
• Eli Lilly And Company
• GlaxoSmithKline
• Johnson & Johnson
• Endo Pharmaceuticals
• Allergen Inc.
• Bayer AG
• Bristol-Myers Squibb
• Valeant Pharmaceuticals International Inc.
• Boehringer Ingelheim
• Sorrento Therapeutics
• WEX Pharmaceuticals
• Zynerba Pharmaceuticals
• GSK
• Grunenthal
• AstraZeneca
• Depomed
• Teva
• Allergan

Frequently Asked Questions:

1] What segments are covered in the Global Pain management drugs Market report?
Ans. The segments covered in the Market report are based on Therapeutic Indication, category, and brand.

2] Which region is expected to hold the highest share in the Global  Market?
Ans. The North American region is expected to hold the highest share in Market.

3] What is the market size of the Global  Market by 2029?
Ans. The market size of the Global  Market by 2029 is expected to reach US$ 58.16 Bn.

4] What is the forecast period for the Global Market?
Ans. The forecast period for the Market is 2022-2029.

5] What was the market size of the Global Market in 2021?
Ans. The market size of the Global  Market in 2021 was valued at US$ 38.91Bn. 





Global pain management drugs market

1. Preface
1.1. Research Objectives
1.2. Report Scope and Market Segmentation

2. Assumptions and Research Methodology
2.1. Abbreviations

3. Executive Summary
3.1. Global Pain Management Drugs Market Size, by Market Value (US$ Bn) and Market

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.3.7. Key Trends in Global Pain Management Drugs Market

5. Global Pain Management Drugs Market Analysis and Forecast
5.1. Global Pain Management Drugs Market Size& Y-o-Y Growth Analysis
5.1.1. North America
5.1.2. Europe
5.1.3. Asia Pacific
5.1.4. Middle East & Africa
5.1.5. South America

6. Global Pain Management Drugs Market Analysis and Forecast, By Category
6.1. Introduction and Definition
6.2. Global Pain Management Drugs Market Value Share Analysis, By Category
6.3. Global Pain Management Drugs Market Size (US$ Bn) Forecast, By Category
6.4. Global Pain Management Drugs Market Analysis, By Category
6.5. Global Pain Management Drugs Market Attractiveness Analysis, By Category
6.6. Key Trends
6.6.1. Key Developments

7. Global Pain Management Drugs Market Analysis and Forecast, By Therapeutic Indications
7.1. Introduction and Definition
7.2. Global Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications
7.3. Global Pain Management Drugs Market Size (US$ Bn) Forecast, By Therapeutic Indications
7.4. Global Pain Management Drugs Market Analysis, By Therapeutic Indications
7.5. Global Pain Management Drugs Market Attractiveness Analysis, By Therapeutic Indications
7.6. Key Trends
7.6.1. Key Developments

8. Global Pain Management Drugs Market Analysis and Forecast, By Brands
8.1. Introduction and Definition
8.2. Global Pain Management Drugs Market Value Share Analysis, By Brands
8.3. Global Pain Management Drugs Market Size (US$ Bn) Forecast, By Brands
8.4. Global Pain Management Drugs Market Analysis, By Brands
8.5. Global Pain Management Drugs Market Attractiveness Analysis, By Brands
8.6. Key Trends
8.6.1. Key Developments

9. Global Pain Management Drugs Market Analysis, by Region
9.1. Global Pain Management Drugs Market Value Share Analysis, by Region
9.2. Global Pain Management Drugs Market Size (US$ Bn) Forecast, by Region
9.3. Global Pain Management Drugs Market Attractiveness Analysis, by Region
9.4. Key Trends
9.4.1. Key Developments

10. North America Pain Management Drugs Market Analysis
10.1. North America Pain Management Drugs Market Overview
10.2. North America Pain Management Drugs Market Value Share Analysis, By Category
10.3. North America Pain Management Drugs Market Forecast, By Category
10.3.1. Prescription-Based Drugs
10.3.2. Over-The-Counter (OTC) Drugs
10.4. North America Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications
10.5. North America Pain Management Drugs Market Forecast, By Therapeutic Indications
10.5.1. Post-Operative Pain
10.5.2. Low-Back Pain
10.5.3. Rheumatoid Arthritis Pain
10.5.4. Osteoarthritis Pain
10.5.5. Cancer Pain
10.5.6. Migraine
10.5.7. Neuropathic Pain
10.5.8. Fibromyalgia
10.5.9. Others
10.6. North America Pain Management Drugs Market Value Share Analysis, By Brands
10.7. North America Pain Management Drugs Market Forecast, By Brands
10.7.1. Maxalt
10.7.2. Zomig
10.7.3. Qutenza
10.7.4. Lidoderm
10.7.5. Savella
10.7.6. Imitrex
10.7.7. Voltaren Gel
10.7.8. Celebrex
10.7.9. Cymbalta
10.7.10. Others
10.8. North America Pain Management Drugs Market Value Share Analysis, by Country
10.9. North America Pain Management Drugs Market Forecast, by Country
10.9.1. U.S.
10.9.2. Canada
10.10. North America Pain Management Drugs Market Analysis, by Country
10.11. U.S. Pain Management Drugs Market Forecast, By Category
10.11.1. Prescription-Based Drugs
10.11.2. Over-The-Counter (OTC) Drugs
10.12. U.S. Pain Management Drugs Market Forecast, By Therapeutic Indications
10.12.1. Post-Operative Pain
10.12.2. Low-Back Pain
10.12.3. Rheumatoid Arthritis Pain
10.12.4. Osteoarthritis Pain
10.12.5. Cancer Pain
10.12.6. Migraine
10.12.7. Neuropathic Pain
10.12.8. Fibromyalgia
10.12.9. Others
10.13. U.S. Pain Management Drugs Market Forecast, By Brands
10.13.1. Maxalt
10.13.2. Zomig
10.13.3. Qutenza
10.13.4. Lidoderm
10.13.5. Savella
10.13.6. Imitrex
10.13.7. Voltaren Gel
10.13.8. Celebrex
10.13.9. Cymbalta
10.13.10. Others
10.14. Canada Pain Management Drugs Market Forecast, By Category
10.14.1. Prescription-Based Drugs
10.14.2. Over-The-Counter (OTC) Drugs
10.15. Canada Pain Management Drugs Market Forecast, By Therapeutic Indications
10.15.1. Post-Operative Pain
10.15.2. Low-Back Pain
10.15.3. Rheumatoid Arthritis Pain
10.15.4. Osteoarthritis Pain
10.15.5. Cancer Pain
10.15.6. Migraine
10.15.7. Neuropathic Pain
10.15.8. Fibromyalgia
10.15.9. Others
10.16. Canada Pain Management Drugs Market Forecast, By Brands
10.16.1. Maxalt
10.16.2. Zomig
10.16.3. Qutenza
10.16.4. Lidoderm
10.16.5. Savella
10.16.6. Imitrex
10.16.7. Voltaren Gel
10.16.8. Celebrex
10.16.9. Cymbalta
10.16.10. Others
10.17. North America Pain Management Drugs Market Attractiveness Analysis
10.17.1. By Category
10.17.2. By Therapeutic Indications
10.17.3. By Brands
10.18. PEST Analysis
10.19. Key Trends
10.19.1. Key Developments

11. Europe Pain Management Drugs Market Analysis
11.1. Europe Pain Management Drugs Market Overview
11.2. Europe Pain Management Drugs Market Value Share Analysis, By Category
11.3. Europe Pain Management Drugs Market Forecast, By Category
11.3.1. Prescription-Based Drugs
11.3.2. Over-The-Counter (OTC) Drugs
11.4. Europe Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications
11.5. Europe Pain Management Drugs Market Forecast, By Therapeutic Indications
11.5.1. Post-Operative Pain
11.5.2. Low-Back Pain
11.5.3. Rheumatoid Arthritis Pain
11.5.4. Osteoarthritis Pain
11.5.5. Cancer Pain
11.5.6. Migraine
11.5.7. Neuropathic Pain
11.5.8. Fibromyalgia
11.5.9. Others
11.6. Europe Pain Management Drugs Market Value Share Analysis, By Brands
11.7. Europe Pain Management Drugs Market Forecast, By Brands
11.7.1. Maxalt
11.7.2. Zomig
11.7.3. Qutenza
11.7.4. Lidoderm
11.7.5. Savella
11.7.6. Imitrex
11.7.7. Voltaren Gel
11.7.8. Celebrex
11.7.9. Cymbalta
11.7.10. Others
11.8. Europe Pain Management Drugs Market Value Share Analysis, by Country
11.9. Europe Pain Management Drugs Market Forecast, by Country
11.9.1. Germany
11.9.2. U.K.
11.9.3. France
11.9.4. Italy
11.9.5. Spain
11.9.6. Rest of Europe
11.10. Europe Pain Management Drugs Market Analysis, by Country/ Sub-region
11.11. Germany Pain Management Drugs Market Forecast, By Category
11.11.1. Prescription-Based Drugs
11.11.2. Over-The-Counter (OTC) Drugs
11.12. Germany Pain Management Drugs Market Forecast, By Therapeutic Indications
11.12.1. Post-Operative Pain
11.12.2. Low-Back Pain
11.12.3. Rheumatoid Arthritis Pain
11.12.4. Osteoarthritis Pain
11.12.5. Cancer Pain
11.12.6. Migraine
11.12.7. Neuropathic Pain
11.12.8. Fibromyalgia
11.12.9. Others
11.13. Germany Pain Management Drugs Market Forecast, By Brands
11.13.1. Maxalt
11.13.2. Zomig
11.13.3. Qutenza
11.13.4. Lidoderm
11.13.5. Savella
11.13.6. Imitrex
11.13.7. Voltaren Gel
11.13.8. Celebrex
11.13.9. Cymbalta
11.13.10. Others
11.14. U.K. Pain Management Drugs Market Forecast, By Category
11.14.1. Prescription-Based Drugs
11.14.2. Over-The-Counter (OTC) Drugs
11.15. U.K. Pain Management Drugs Market Forecast, By Therapeutic Indications
11.15.1. Post-Operative Pain
11.15.2. Low-Back Pain
11.15.3. Rheumatoid Arthritis Pain
11.15.4. Osteoarthritis Pain
11.15.5. Cancer Pain
11.15.6. Migraine
11.15.7. Neuropathic Pain
11.15.8. Fibromyalgia
11.15.9. Others
11.16. U.K. Pain Management Drugs Market Forecast, By Brands
11.16.1. Maxalt
11.16.2. Zomig
11.16.3. Qutenza
11.16.4. Lidoderm
11.16.5. Savella
11.16.6. Imitrex
11.16.7. Voltaren Gel
11.16.8. Celebrex
11.16.9. Cymbalta
11.16.10. Others
11.17. France Pain Management Drugs Market Forecast, By Category
11.17.1. Prescription-Based Drugs
11.17.2. Over-The-Counter (OTC) Drugs
11.18. France Pain Management Drugs Market Forecast, By Therapeutic Indications
11.18.1. Post-Operative Pain
11.18.2. Low-Back Pain
11.18.3. Rheumatoid Arthritis Pain
11.18.4. Osteoarthritis Pain
11.18.5. Cancer Pain
11.18.6. Migraine
11.18.7. Neuropathic Pain
11.18.8. Fibromyalgia
11.18.9. Others
11.19. France Pain Management Drugs Market Forecast, By Brands
11.19.1. Maxalt
11.19.2. Zomig
11.19.3. Qutenza
11.19.4. Lidoderm
11.19.5. Savella
11.19.6. Imitrex
11.19.7. Voltaren Gel
11.19.8. Celebrex
11.19.9. Cymbalta
11.19.10. Others
11.20. Italy Pain Management Drugs Market Forecast, By Category
11.20.1. Prescription-Based Drugs
11.20.2. Over-The-Counter (OTC) Drugs
11.21. Italy Pain Management Drugs Market Forecast, By Therapeutic Indications
11.21.1. Post-Operative Pain
11.21.2. Low-Back Pain
11.21.3. Rheumatoid Arthritis Pain
11.21.4. Osteoarthritis Pain
11.21.5. Cancer Pain
11.21.6. Migraine
11.21.7. Neuropathic Pain
11.21.8. Fibromyalgia
11.21.9. Others
11.22. Italy Pain Management Drugs Market Forecast, By Brands
11.22.1. Maxalt
11.22.2. Zomig
11.22.3. Qutenza
11.22.4. Lidoderm
11.22.5. Savella
11.22.6. Imitrex
11.22.7. Voltaren Gel
11.22.8. Celebrex
11.22.9. Cymbalta
11.22.10. Others
11.23. Spain Pain Management Drugs Market Forecast, By Category
11.23.1. Prescription-Based Drugs
11.23.2. Over-The-Counter (OTC) Drugs
11.24. Spain Pain Management Drugs Market Forecast, By Therapeutic Indications
11.24.1. Post-Operative Pain
11.24.2. Low-Back Pain
11.24.3. Rheumatoid Arthritis Pain
11.24.4. Osteoarthritis Pain
11.24.5. Cancer Pain
11.24.6. Migraine
11.24.7. Neuropathic Pain
11.24.8. Fibromyalgia
11.24.9. Others
11.25. Spain Pain Management Drugs Market Forecast, By Brands
11.25.1. Maxalt
11.25.2. Zomig
11.25.3. Qutenza
11.25.4. Lidoderm
11.25.5. Savella
11.25.6. Imitrex
11.25.7. Voltaren Gel
11.25.8. Celebrex
11.25.9. Cymbalta
11.25.10. Others
11.26. Rest of Europe Pain Management Drugs Market Forecast, By Category
11.26.1. Prescription-Based Drugs
11.26.2. Over-The-Counter (OTC) Drugs
11.27. Rest of Europe Pain Management Drugs Market Forecast, By Therapeutic Indications
11.27.1. Post-Operative Pain
11.27.2. Low-Back Pain
11.27.3. Rheumatoid Arthritis Pain
11.27.4. Osteoarthritis Pain
11.27.5. Cancer Pain
11.27.6. Migraine
11.27.7. Neuropathic Pain
11.27.8. Fibromyalgia
11.27.9. Others
11.28. Rest of Europe Pain Management Drugs Market Forecast, By Brands
11.28.1. Maxalt
11.28.2. Zomig
11.28.3. Qutenza
11.28.4. Lidoderm
11.28.5. Savella
11.28.6. Imitrex
11.28.7. Voltaren Gel
11.28.8. Celebrex
11.28.9. Cymbalta
11.28.10. Others
11.29. Europe Pain Management Drugs Market Attractiveness Analysis
11.29.1. By Category
11.29.2. By Therapeutic Indications
11.29.3. By Brands
11.30. PEST Analysis
11.31. Key Trends
11.31.1. Key Developments

12. Asia Pacific Pain Management Drugs Market Analysis
12.1. Asia Pacific Pain Management Drugs Market Overview
12.2. Asia Pacific Pain Management Drugs Market Value Share Analysis, By Category
12.3. Asia Pacific Pain Management Drugs Market Forecast, By Category
12.3.1. Prescription-Based Drugs
12.3.2. Over-The-Counter (OTC) Drugs
12.4. Asia Pacific Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications
12.5. Asia Pacific Pain Management Drugs Market Forecast, By Therapeutic Indications
12.5.1. Post-Operative Pain
12.5.2. Low-Back Pain
12.5.3. Rheumatoid Arthritis Pain
12.5.4. Osteoarthritis Pain
12.5.5. Cancer Pain
12.5.6. Migraine
12.5.7. Neuropathic Pain
12.5.8. Fibromyalgia
12.5.9. Others
12.6. Asia Pacific Pain Management Drugs Market Value Share Analysis, By Brands
12.7. Asia Pacific Pain Management Drugs Market Forecast, By Brands
12.7.1. Maxalt
12.7.2. Zomig
12.7.3. Qutenza
12.7.4. Lidoderm
12.7.5. Savella
12.7.6. Imitrex
12.7.7. Voltaren Gel
12.7.8. Celebrex
12.7.9. Cymbalta
12.7.10. Others
12.8. Asia Pacific Pain Management Drugs Market Value Share Analysis, by Country
12.9. Asia Pacific Pain Management Drugs Market Forecast, by Country
12.9.1. China
12.9.2. India
12.9.3. Japan
12.9.4. ASEAN
12.9.5. Rest of Asia Pacific
12.10. Asia Pacific Pain Management Drugs Market Analysis, by Country/ Sub-region
12.11. China Pain Management Drugs Market Forecast, By Category
12.11.1. Prescription-Based Drugs
12.11.2. Over-The-Counter (OTC) Drugs
12.12. China Pain Management Drugs Market Forecast, By Therapeutic Indications
12.12.1. Post-Operative Pain
12.12.2. Low-Back Pain
12.12.3. Rheumatoid Arthritis Pain
12.12.4. Osteoarthritis Pain
12.12.5. Cancer Pain
12.12.6. Migraine
12.12.7. Neuropathic Pain
12.12.8. Fibromyalgia
12.12.9. Others
12.13. China Pain Management Drugs Market Forecast, By Brands
12.13.1. Maxalt
12.13.2. Zomig
12.13.3. Qutenza
12.13.4. Lidoderm
12.13.5. Savella
12.13.6. Imitrex
12.13.7. Voltaren Gel
12.13.8. Celebrex
12.13.9. Cymbalta
12.13.10. Others
12.14. India Pain Management Drugs Market Forecast, By Category
12.14.1. Prescription-Based Drugs
12.14.2. Over-The-Counter (OTC) Drugs
12.15. India Pain Management Drugs Market Forecast, By Therapeutic Indications
12.15.1. Post-Operative Pain
12.15.2. Low-Back Pain
12.15.3. Rheumatoid Arthritis Pain
12.15.4. Osteoarthritis Pain
12.15.5. Cancer Pain
12.15.6. Migraine
12.15.7. Neuropathic Pain
12.15.8. Fibromyalgia
12.15.9. Others
12.16. India Pain Management Drugs Market Forecast, By Brands
12.16.1. Maxalt
12.16.2. Zomig
12.16.3. Qutenza
12.16.4. Lidoderm
12.16.5. Savella
12.16.6. Imitrex
12.16.7. Voltaren Gel
12.16.8. Celebrex
12.16.9. Cymbalta
12.16.10. Others
12.17. Japan Pain Management Drugs Market Forecast, By Category
12.17.1. Prescription-Based Drugs
12.17.2. Over-The-Counter (OTC) Drugs
12.18. Japan Pain Management Drugs Market Forecast, By Therapeutic Indications
12.18.1. Post-Operative Pain
12.18.2. Low-Back Pain
12.18.3. Rheumatoid Arthritis Pain
12.18.4. Osteoarthritis Pain
12.18.5. Cancer Pain
12.18.6. Migraine
12.18.7. Neuropathic Pain
12.18.8. Fibromyalgia
12.18.9. Others
12.19. Japan Pain Management Drugs Market Forecast, By Brands
12.19.1. Maxalt
12.19.2. Zomig
12.19.3. Qutenza
12.19.4. Lidoderm
12.19.5. Savella
12.19.6. Imitrex
12.19.7. Voltaren Gel
12.19.8. Celebrex
12.19.9. Cymbalta
12.19.10. Others
12.20. ASEAN Pain Management Drugs Market Forecast, By Category
12.20.1. Prescription-Based Drugs
12.20.2. Over-The-Counter (OTC) Drugs
12.21. ASEAN Pain Management Drugs Market Forecast, By Therapeutic Indications
12.21.1. Post-Operative Pain
12.21.2. Low-Back Pain
12.21.3. Rheumatoid Arthritis Pain
12.21.4. Osteoarthritis Pain
12.21.5. Cancer Pain
12.21.6. Migraine
12.21.7. Neuropathic Pain
12.21.8. Fibromyalgia
12.21.9. Others
12.22. ASEAN Pain Management Drugs Market Forecast, By Brands
12.22.1. Maxalt
12.22.2. Zomig
12.22.3. Qutenza
12.22.4. Lidoderm
12.22.5. Savella
12.22.6. Imitrex
12.22.7. Voltaren Gel
12.22.8. Celebrex
12.22.9. Cymbalta
12.22.10. Others
12.23. Rest of Asia Pacific Pain Management Drugs Market Forecast, By Category
12.23.1. Prescription-Based Drugs
12.23.2. Over-The-Counter (OTC) Drugs
12.24. Rest of Asia Pacific Pain Management Drugs Market Forecast, By Therapeutic Indications
12.24.1. Post-Operative Pain
12.24.2. Low-Back Pain
12.24.3. Rheumatoid Arthritis Pain
12.24.4. Osteoarthritis Pain
12.24.5. Cancer Pain
12.24.6. Migraine
12.24.7. Neuropathic Pain
12.24.8. Fibromyalgia
12.24.9. Others
12.25. Rest of Asia Pacific Pain Management Drugs Market Forecast, By Brands
12.25.1. Maxalt
12.25.2. Zomig
12.25.3. Qutenza
12.25.4. Lidoderm
12.25.5. Savella
12.25.6. Imitrex
12.25.7. Voltaren Gel
12.25.8. Celebrex
12.25.9. Cymbalta
12.25.10. Others
12.26. Asia Pacific Pain Management Drugs Market Attractiveness Analysis
12.26.1. By Category
12.26.2. By Therapeutic Indications
12.26.3. By Brands
12.27. PEST Analysis
12.28. Key Trends
12.28.1. Key Developments

13. Middle East & Africa Pain Management Drugs Market Analysis
13.1. Middle East & Africa Pain Management Drugs Market Overview
13.2. Middle East & Africa Pain Management Drugs Market Value Share Analysis, By Category
13.3. Middle East & Africa Pain Management Drugs Market Forecast, By Category
13.3.1. Prescription-Based Drugs
13.3.2. Over-The-Counter (OTC) Drugs
13.4. Middle East & Africa Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications
13.5. Middle East & Africa Pain Management Drugs Market Forecast, By Therapeutic Indications
13.5.1. Post-Operative Pain
13.5.2. Low-Back Pain
13.5.3. Rheumatoid Arthritis Pain
13.5.4. Osteoarthritis Pain
13.5.5. Cancer Pain
13.5.6. Migraine
13.5.7. Neuropathic Pain
13.5.8. Fibromyalgia
13.5.9. Others
13.6. Middle East & Africa Pain Management Drugs Market Value Share Analysis, By Brands
13.7. Middle East & Africa Pain Management Drugs Market Forecast, By Brands
13.7.1. Maxalt
13.7.2. Zomig
13.7.3. Qutenza
13.7.4. Lidoderm
13.7.5. Savella
13.7.6. Imitrex
13.7.7. Voltaren Gel
13.7.8. Celebrex
13.7.9. Cymbalta
13.7.10. Others
13.8. Middle East & Africa Pain Management Drugs Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Pain Management Drugs Market Analysis, by Country/ Sub-region
13.10. GCC Pain Management Drugs Market Forecast, By Category
13.10.1. Prescription-Based Drugs
13.10.2. Over-The-Counter (OTC) Drugs
13.11. GCC Pain Management Drugs Market Forecast, By Therapeutic Indications
13.11.1. Post-Operative Pain
13.11.2. Low-Back Pain
13.11.3. Rheumatoid Arthritis Pain
13.11.4. Osteoarthritis Pain
13.11.5. Cancer Pain
13.11.6. Migraine
13.11.7. Neuropathic Pain
13.11.8. Fibromyalgia
13.11.9. Others
13.12. GCC Pain Management Drugs Market Forecast, By Brands
13.12.1. Maxalt
13.12.2. Zomig
13.12.3. Qutenza
13.12.4. Lidoderm
13.12.5. Savella
13.12.6. Imitrex
13.12.7. Voltaren Gel
13.12.8. Celebrex
13.12.9. Cymbalta
13.12.10. Others
13.13. Others South Africa Pain Management Drugs Market Forecast, By Category
13.13.1. Prescription-Based Drugs
13.13.2. Over-The-Counter (OTC) Drugs
13.14. South Africa Pain Management Drugs Market Forecast, By Therapeutic Indications
13.14.1. Post-Operative Pain
13.14.2. Low-Back Pain
13.14.3. Rheumatoid Arthritis Pain
13.14.4. Osteoarthritis Pain
13.14.5. Cancer Pain
13.14.6. Migraine
13.14.7. Neuropathic Pain
13.14.8. Fibromyalgia
13.14.9. Others
13.15. South Africa Pain Management Drugs Market Forecast, By Brands
13.15.1. Maxalt
13.15.2. Zomig
13.15.3. Qutenza
13.15.4. Lidoderm
13.15.5. Savella
13.15.6. Imitrex
13.15.7. Voltaren Gel
13.15.8. Celebrex
13.15.9. Cymbalta
13.15.10. Others
13.16. Rest of Middle East & Africa Pain Management Drugs Market Forecast, By Category
13.16.1. Prescription-Based Drugs
13.16.2. Over-The-Counter (OTC) Drugs
13.17. Rest of Middle East & Africa Pain Management Drugs Market Forecast, By Therapeutic Indications
13.17.1. Post-Operative Pain
13.17.2. Low-Back Pain
13.17.3. Rheumatoid Arthritis Pain
13.17.4. Osteoarthritis Pain
13.17.5. Cancer Pain
13.17.6. Migraine
13.17.7. Neuropathic Pain
13.17.8. Fibromyalgia
13.17.9. Others
13.18. Rest of Middle East & Africa Pain Management Drugs Market Forecast, By Brands
13.18.1. Maxalt
13.18.2. Zomig
13.18.3. Qutenza
13.18.4. Lidoderm
13.18.5. Savella
13.18.6. Imitrex
13.18.7. Voltaren Gel
13.18.8. Celebrex
13.18.9. Cymbalta
13.18.10. Others
13.19. Middle East & Africa Pain Management Drugs Market Attractiveness Analysis
13.19.1. By Category
13.19.2. By Therapeutic Indications
13.19.3. By Brands
13.20. PEST Analysis
13.21. Key Trends
13.21.1. Key Developments

14. South America Pain Management Drugs Market Analysis
14.1. South America Pain Management Drugs Market Overview
14.2. South America Pain Management Drugs Market Value Share Analysis, By Category
14.3. South America Pain Management Drugs Market Forecast, By Category
14.3.1. Prescription-Based Drugs
14.3.2. Over-The-Counter (OTC) Drugs
14.4. South America Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications
14.5. South America Pain Management Drugs Market Forecast, By Therapeutic Indications
14.5.1. Post-Operative Pain
14.5.2. Low-Back Pain
14.5.3. Rheumatoid Arthritis Pain
14.5.4. Osteoarthritis Pain
14.5.5. Cancer Pain
14.5.6. Migraine
14.5.7. Neuropathic Pain
14.5.8. Fibromyalgia
14.5.9. Others
14.6. South America Pain Management Drugs Market Value Share Analysis, By Brands
14.7. South America Pain Management Drugs Market Forecast, By Brands
14.7.1. Maxalt
14.7.2. Zomig
14.7.3. Qutenza
14.7.4. Lidoderm
14.7.5. Savella
14.7.6. Imitrex
14.7.7. Voltaren Gel
14.7.8. Celebrex
14.7.9. Cymbalta
14.7.10. Others
14.8. South America Pain Management Drugs Market Value Share Analysis, by Country
14.9. South America Pain Management Drugs Market Forecast, by Country
14.9.1. Brazil
14.9.2. Mexico
14.9.3. Rest of South America
14.10. South America Pain Management Drugs Market Analysis, by Country/ Sub-region
14.11. Brazil Pain Management Drugs Market Forecast, By Category
14.11.1. Prescription-Based Drugs
14.11.2. Over-The-Counter (OTC) Drugs
14.12. Brazil Pain Management Drugs Market Forecast, By Therapeutic Indications
14.12.1. Post-Operative Pain
14.12.2. Low-Back Pain
14.12.3. Rheumatoid Arthritis Pain
14.12.4. Osteoarthritis Pain
14.12.5. Cancer Pain
14.12.6. Migraine
14.12.7. Neuropathic Pain
14.12.8. Fibromyalgia
14.12.9. Others
14.13. Brazil Pain Management Drugs Market Forecast, By Brands
14.13.1. Maxalt
14.13.2. Zomig
14.13.3. Qutenza
14.13.4. Lidoderm
14.13.5. Savella
14.13.6. Imitrex
14.13.7. Voltaren Gel
14.13.8. Celebrex
14.13.9. Cymbalta
14.13.10. Others
14.14. Mexico Pain Management Drugs Market Forecast, By Category
14.14.1. Prescription-Based Drugs
14.14.2. Over-The-Counter (OTC) Drugs
14.15. Mexico Pain Management Drugs Market Forecast, By Therapeutic Indications
14.15.1. Post-Operative Pain
14.15.2. Low-Back Pain
14.15.3. Rheumatoid Arthritis Pain
14.15.4. Osteoarthritis Pain
14.15.5. Cancer Pain
14.15.6. Migraine
14.15.7. Neuropathic Pain
14.15.8. Fibromyalgia
14.15.9. Others
14.16. Mexico Pain Management Drugs Market Forecast, By Brands
14.16.1. Maxalt
14.16.2. Zomig
14.16.3. Qutenza
14.16.4. Lidoderm
14.16.5. Savella
14.16.6. Imitrex
14.16.7. Voltaren Gel
14.16.8. Celebrex
14.16.9. Cymbalta
14.16.10. Others
14.17. Rest of South America Pain Management Drugs Market Forecast, By Category
14.17.1. Prescription-Based Drugs
14.17.2. Over-The-Counter (OTC) Drugs
14.18. Rest of South America Pain Management Drugs Market Forecast, By Therapeutic Indications
14.18.1. Post-Operative Pain
14.18.2. Low-Back Pain
14.18.3. Rheumatoid Arthritis Pain
14.18.4. Osteoarthritis Pain
14.18.5. Cancer Pain
14.18.6. Migraine
14.18.7. Neuropathic Pain
14.18.8. Fibromyalgia
14.18.9. Others
14.19. Rest of South America Pain Management Drugs Market Forecast, By Brands
14.19.1. Maxalt
14.19.2. Zomig
14.19.3. Qutenza
14.19.4. Lidoderm
14.19.5. Savella
14.19.6. Imitrex
14.19.7. Voltaren Gel
14.19.8. Celebrex
14.19.9. Cymbalta
14.19.10. Others
14.20. South America Pain Management Drugs Market Attractiveness Analysis
14.20.1. By Category
14.20.2. By Therapeutic Indications
14.20.3. By Brands
14.21. PEST Analysis
14.22. Key Trends
14.22.1. Key Developments

15. Company Landscape
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.3. Competitive Benchmarking of Company and Services
15.4. Company Profiles: Key Players
15.4.1. Pfizer, Inc.
15.4.1.1. Company Overview
15.4.1.2. Financial Overview
15.4.1.3. Business Strategy
15.4.1.4. Recent Developments
15.4.1.5. Development Footprint
15.4.2. Purdue Pharma L.P.
15.4.3. Eli Lilly And Company
15.4.4. GlaxoSmithKline
15.4.5. Johnson & Johnson
15.4.6. Endo Pharmaceuticals
15.4.7. Allergen Inc.
15.4.8. Bayer AG
15.4.9. Bristol-Myers Squibb
15.4.10. Valeant Pharmaceuticals International Inc.
15.4.11. Boehringer Ingelheim
15.4.12. Sorrento Therapeutics
15.4.13. WEX Pharmaceuticals
15.4.14. Zynerba Pharmaceuticals
15.4.15. GSK
15.4.16. Grunenthal
15.4.17. AstraZeneca
15.4.18. Depomed
15.4.19. Teva
15.4.20. Allergan

16. Primary Key Insights
  • INQUIRE BEFORE BUYING